BusinessSemiconductors

Semiconductor IP Market Set for Robust Expansion, Projected to Reach $15.68 Billion by 2032

The semiconductor intellectual property market is positioned for substantial growth, with analysts projecting it will reach $15.68 billion by 2032. This expansion is reportedly driven by increasing demand for reusable IP cores across consumer electronics, automotive, and industrial applications as chip designs grow more complex.

Market Projections and Growth Trajectory

The semiconductor intellectual property (IP) market is experiencing significant expansion and is projected to reach $15.68 billion by 2032, according to recent market analysis. The sector, valued at $7.04 billion in 2023, is expected to grow at a compound annual growth rate (CAGR) of 9.77% from 2024 to 2032, according to reports. Industry analysts suggest this growth trajectory underscores the increasing strategic importance of IP cores in the global semiconductor ecosystem as technological complexity intensifies.

Assistive TechnologyGaming Hardware

Digital Archaeology: The Extreme Measures Required to Resurrect Classic Games

The quest to revive classic games involves far more than technical wizardry, according to industry insiders. GOG’s preservation specialists describe hunting for inheritance recipients unaware they own valuable gaming IP and developers whose paper records have been destroyed by fire.

The Hidden Challenges of Game Preservation

Digital game preservation faces unprecedented legal and logistical hurdles that extend far beyond mere technical compatibility, according to reports from industry specialists. While demand for classic titles remains strong, sources indicate that red tape and complex intellectual property issues prevent many beloved games from returning to the market.

Arts and EntertainmentAssistive Technology

Pharma Industry Faces Trust Gap with Agentic AI Adoption, Reports Suggest

The pharmaceutical industry is approaching agentic AI with significant caution, with reports indicating only 50% of professionals trust AI for consistent accuracy. Trust levels drop further for critical decisions involving drug pipelines and intellectual property protection, creating adoption challenges.

Pharma’s Cautious Approach to Agentic AI Implementation

The pharmaceutical industry is developing a divided market regarding artificial intelligence adoption, with sources indicating that rapid adopters with substantial budgets are moving toward standardized agentic systems while more cautious organizations focus on targeted pilot programs. According to reports, companies pursuing specific use cases with clear return on investment pathways represent the more measured approach to integration.